2013
A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin
HEGER, Zbynek, Natalia CERNEI, Jiri KUDR, Jaromír GUMULEC, Iva BLAZKOVA et. al.Základní údaje
Originální název
A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin
Autoři
HEGER, Zbynek (203 Česká republika), Natalia CERNEI (203 Česká republika), Jiri KUDR (203 Česká republika), Jaromír GUMULEC (203 Česká republika, garant, domácí), Iva BLAZKOVA (203 Česká republika), Ondrej ZITKA (203 Česká republika), Tomas ECKSCHLAGER (203 Česká republika), Marie STIBOROVA (203 Česká republika), Vojtech ADAM (203 Česká republika) a Rene KIZEK (203 Česká republika)
Vydání
International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2013, 1422-0067
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.339
Kód RIV
RIV/00216224:14110/13:00070887
Organizační jednotka
Lékařská fakulta
UT WoS
000328624400027
Klíčová slova anglicky
Amide bond; Cardiomyopathy; Interaction; Ion-exchange liquid chromatography; Myocardium; Spectrophotometry
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 2. 2014 10:48, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Doxorubicin is a commonly used antineoplastic agent in the treatment of many types of cancer. Little is known about the interactions of doxorubicin with cardiac biomolecules. Serious cardiotoxicity including dilated cardiomyopathy often resulting in a fatal congestive heart failure may occur as a consequence of chemotherapy with doxorubicin. The purpose of this study was to determine the effect of exposure to doxorubicin on the changes in major amino acids in tissue of cardiac muscle (proline, taurine, glutamic acid, arginine, aspartic acid, leucine, glycine, valine, alanine, isoleucine, threonine, lysine and serine). An in vitro interaction study was performed as a comparison of amino acid profiles in heart tissue before and after application of doxorubicin. We found that doxorubicin directly influences myocardial amino acid representation even at low concentrations. In addition, we performed an interaction study that resulted in the determination of breaking points for each of analyzed amino acids. Lysine, arginine, beta-alanine, valine and serine were determined as the most sensitive amino acids. Additionally we compared amino acid profiles of myocardium before and after exposure to doxorubicin. The amount of amino acids after interaction with doxorubicin was significantly reduced (p = 0.05). This fact points at an ability of doxorubicin to induce changes in quantitative composition of amino acids in myocardium. Moreover, this confirms that the interactions between doxorubicin and amino acids may act as another factor most likely responsible for adverse effects of doxorubicin on myocardium.
Návaznosti
ED1.1.00/02.0068, projekt VaV |
|